Efficacy and safety of TE/TEC/intensive paclitaxel neoadjuvant chemotherapy for the treatment of breast cancer

Efficacy and safety of paclitaxel/docetaxel + epirubicin (TE), paclitaxel/docetaxel + epirubicin + cytoxan (TEC) and intensive paclitaxel (IP) neoadjuvant chemotherapy (NCT) were compared for the treatment of breast cancer. The clinical data of 326 patients with stage II–III unilateral primary breas...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yang, Xu, Zhaoguo, Zhang, Zhenyong, Wen, Guangfu, Sun, Jiaxing, Han, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312931/
https://www.ncbi.nlm.nih.gov/pubmed/30655846
http://dx.doi.org/10.3892/ol.2018.9658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312931/
https://www.ncbi.nlm.nih.gov/pubmed/30655846
http://dx.doi.org/10.3892/ol.2018.9658

Ejemplares similares